BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18350402)

  • 1. Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?
    Bottero P; Motta F; Bonini M; Vecchio F; Ierna F; Cuppari I; Sinico RA
    ISRN Rheumatol; 2014; 2014():843804. PubMed ID: 24734195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Churg-strauss syndrome in patients treated with omalizumab.
    Wechsler ME; Wong DA; Miller MK; Lawrence-Miyasaki L
    Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Churg-Strauss syndrome in a patient treated with omalizumab.
    Cisneros C; Segrelles G; Herráez L; Gonzalez A; Girón R
    J Investig Allergol Clin Immunol; 2013; 23(7):515-6. PubMed ID: 24654320
    [No Abstract]   [Full Text] [Related]  

  • 4. Switching from omalizumab to mepolizumab therapy improved extra-pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis.
    Chen YH; Kuo PH
    Respirol Case Rep; 2022 Jan; 10(1):e0878. PubMed ID: 34876987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
    Carson LN; Pradhan A; Subramanian D
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics in Dermatology: Off-Label Indications.
    Mitra D; Chopra A; Saraswat N; Mitra B; Talukdar K; Agarwal R
    Indian Dermatol Online J; 2020; 11(3):319-327. PubMed ID: 32695686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.
    Pelaia C; Calabrese C; Terracciano R; de Blasio F; Vatrella A; Pelaia G
    Ther Adv Respir Dis; 2018; 12():1753466618810192. PubMed ID: 30400762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple refractory ankle ulcerations in thromboangiitis obliterans: A case report.
    Huang ZH; Kuo SY; Chiu YH; Chen HC; Lu CC
    Medicine (Baltimore); 2018 May; 97(20):e10798. PubMed ID: 29768374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.
    Licari A; Castagnoli R; Panfili E; Marseglia A; Brambilla I; Marseglia GL
    Curr Respir Med Rev; 2017 Mar; 13(1):22-29. PubMed ID: 29290750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-Label Uses of Omalizumab.
    El-Qutob D
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):84-96. PubMed ID: 26048266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapies for allergic inflammation: refining strategies to induce tolerance.
    Akdis CA
    Nat Med; 2012 May; 18(5):736-49. PubMed ID: 22561837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on optimal use of omalizumab in management of asthma.
    Pelaia G; Gallelli L; Renda T; Romeo P; Busceti MT; Grembiale RD; Maselli R; Marsico SA; Vatrella A
    J Asthma Allergy; 2011; 4():49-59. PubMed ID: 21792319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vasculitis: clinical presentation, differential diagnosis, and management.
    Ramsey J; Amari M; Kantrow SP
    Curr Rheumatol Rep; 2010 Dec; 12(6):420-8. PubMed ID: 20882372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Churg-Strauss syndrome: 2005-2008 update.
    Grau RG
    Curr Rheumatol Rep; 2008 Dec; 10(6):453-8. PubMed ID: 19007535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Churg-Strauss vasculitis in a patient treated with omalizumab.
    Bargagli E; Madioni C; Olivieri C; Penza F; Rottoli P
    J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab administration in Churg-Strauss syndrome.
    Giavina-Bianchi P; Kalil J
    Eur J Intern Med; 2009 Oct; 20(6):e139. PubMed ID: 19782907
    [No Abstract]   [Full Text] [Related]  

  • 17. Administration of anti-IgE to a Churg-Strauss syndrome patient.
    Giavina-Bianchi P; Giavina-Bianchi M; Agondi R; Kalil J
    Int Arch Allergy Immunol; 2007; 144(2):155-8. PubMed ID: 17536214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab treatment associated with Churg-Strauss vasculitis.
    Bargagli E; Rottoli P
    Int Arch Allergy Immunol; 2008; 145(3):268. PubMed ID: 17921677
    [No Abstract]   [Full Text] [Related]  

  • 19. Churg-Strauss syndrome.
    Keogh KA; Specks U
    Semin Respir Crit Care Med; 2006 Apr; 27(2):148-57. PubMed ID: 16612766
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.